These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 38702281)

  • 81. Metabolic response evaluation for colorectal liver metastases and correlation to pathologic response and tumour markers.
    Lau LF; Murone C; Williams DS; Standish R; Lee ST; Christophi C; Scott AM; Muralidharan V
    ANZ J Surg; 2018 Mar; 88(3):E108-E113. PubMed ID: 27452367
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Tumor marker evolution: comparison with imaging for assessment of response to chemotherapy in patients with colorectal liver metastases.
    de Haas RJ; Wicherts DA; Flores E; Ducreux M; Lévi F; Paule B; Azoulay D; Castaing D; Lemoine A; Adam R
    Ann Surg Oncol; 2010 Apr; 17(4):1010-23. PubMed ID: 20052553
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Effectiveness of Hepatic Artery Infusion (HAI) Versus Selective Internal Radiation Therapy (Y90) for Pretreated Isolated Unresectable Colorectal Liver Metastases (IU-CRCLM).
    Dhir M; Zenati MS; Jones HL; Bartlett DL; Choudry MHA; Pingpank JF; Holtzman MP; Bahary N; Hogg ME; Zeh HJ; Geller DA; Wallis Marsh J; Tsung A; Zureikat AH
    Ann Surg Oncol; 2018 Feb; 25(2):550-557. PubMed ID: 29181682
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Repeat hepatectomy for recurrent colorectal liver metastases is associated with a high survival rate.
    Andreou A; Brouquet A; Abdalla EK; Aloia TA; Curley SA; Vauthey JN
    HPB (Oxford); 2011 Nov; 13(11):774-82. PubMed ID: 21999590
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Impact of Neoadjuvant Chemotherapy on the Postoperative Outcomes of Patients Undergoing Liver Resection for Colorectal Liver Metastases: A Population-Based Propensity-Matched Analysis.
    Wiseman JT; Guzman-Pruneda F; Xourafas D; Chun YS; Ejaz A; Tsung A; Pawlik TM; Cloyd JM
    J Am Coll Surg; 2019 Jul; 229(1):69-77.e2. PubMed ID: 30905856
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Management of disappearing lesions after chemotherapy for colorectal liver metastases: Relation between detectability and residual tumors.
    Tani K; Shindoh J; Akamatsu N; Arita J; Kaneko J; Sakamoto Y; Hasegawa K; Kokudo N
    J Surg Oncol; 2018 Feb; 117(2):191-197. PubMed ID: 28876456
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Efficacy of repeat hepatectomy for recurrence following curative hepatectomy for colorectal liver metastases: A Retrospective Cohort Study of 128 patients.
    Hashimoto M; Kobayashi T; Ishiyama K; Ide K; Ohira M; Tahara H; Kuroda S; Hamaoka M; Iwako H; Okimoto M; Ohdan H
    Int J Surg; 2016 Dec; 36(Pt A):96-103. PubMed ID: 27741421
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Impact of simultaneous diaphragm resection during hepatectomy for treatment of metastatic colorectal cancer.
    Li GZ; Turley RS; Lidsky ME; Barbas AS; Reddy SK; Clary BM
    J Gastrointest Surg; 2012 Aug; 16(8):1508-15. PubMed ID: 22739844
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Prognostic implication of mucinous histology in resected colorectal cancer liver metastases.
    Lupinacci RM; Mello ES; Coelho FF; Kruger JA; Perini MV; Pinheiro RS; Fonseca GM; Cecconello I; Herman P
    Surgery; 2014 Jun; 155(6):1062-8. PubMed ID: 24856126
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Portal vein embolization does not affect the long-term survival and risk of cancer recurrence among colorectal liver metastases patients: A prospective cohort study.
    Collin Y; Paré A; Belblidia A; Létourneau R; Plasse M; Dagenais M; Turcotte S; Martel G; Roy A; Lapointe R; Vandenbroucke-Menu F
    Int J Surg; 2019 Jan; 61():42-47. PubMed ID: 30537548
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Preoperative CT during angiography of the liver for colorectal liver metastases.
    Morise Z; Sugioka A; Kato R; Hoshimoto S; Kato T; Ikeda M
    Hepatogastroenterology; 2008; 55(81):188-90. PubMed ID: 18507104
    [TBL] [Abstract][Full Text] [Related]  

  • 92. The Preoperative Lymphocyte-to-Monocyte Ratio is Prognostic of Clinical Outcomes for Patients with Liver-Only Colorectal Metastases in the Neoadjuvant Setting.
    Neofytou K; Smyth EC; Giakoustidis A; Khan AZ; Williams R; Cunningham D; Mudan S
    Ann Surg Oncol; 2015 Dec; 22(13):4353-62. PubMed ID: 25773876
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Sinusoidal obstruction syndrome impairs long-term outcome of colorectal liver metastases treated with resection after neoadjuvant chemotherapy.
    Tamandl D; Klinger M; Eipeldauer S; Herberger B; Kaczirek K; Gruenberger B; Gruenberger T
    Ann Surg Oncol; 2011 Feb; 18(2):421-30. PubMed ID: 20844968
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Recurrence After Liver Resection of Colorectal Liver Metastases: Repeat Resection or Ablation Followed by Hepatic Arterial Infusion Pump Chemotherapy.
    Buisman FE; Filipe WF; Kemeny NE; Narayan RR; Srouji RM; Balachandran VP; Boerner T; Drebin JA; Jarnagin WR; Kingham TP; Wei AC; Grünhagen DJ; Verhoef C; Koerkamp BG; D'Angelica MI
    Ann Surg Oncol; 2021 Feb; 28(2):808-816. PubMed ID: 32648182
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Prognostic significance of
    Shim JR; Lee SD; Han SS; Lee SJ; Lee DE; Kim SK; Kim SH; Park SJ; Oh JH
    Eur J Surg Oncol; 2018 May; 44(5):670-676. PubMed ID: 29459018
    [TBL] [Abstract][Full Text] [Related]  

  • 96. The Impact of Perioperative Red Blood Cell Transfusions on Long-Term Outcomes after Hepatectomy for Colorectal Liver Metastases.
    Hallet J; Tsang M; Cheng ES; Habashi R; Kulyk I; Hanna SS; Coburn NG; Lin Y; Law CH; Karanicolas PJ
    Ann Surg Oncol; 2015 Nov; 22(12):4038-45. PubMed ID: 25752895
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Chemotherapy-induced splenic volume increase is independently associated with major complications after hepatic resection for metastatic colorectal cancer.
    Simpson AL; Leal JN; Pugalenthi A; Allen PJ; DeMatteo RP; Fong Y; Gönen M; Jarnagin WR; Kingham TP; Miga MI; Shia J; Weiser MR; D'Angelica MI
    J Am Coll Surg; 2015 Mar; 220(3):271-80. PubMed ID: 25617913
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Outcomes after repeat hepatic resection for recurrent metastatic colorectal cancer: A population-based study.
    Nanji S; Tsang ME; Wei X; Booth CM
    Am J Surg; 2017 Jun; 213(6):1053-1059. PubMed ID: 27697193
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Recurrent tumor after resection of hepatic metastases from colorectal carcinoma: location and time of discovery as determined by CT.
    Harned RK; Chezmar JL; Nelson RC
    AJR Am J Roentgenol; 1994 Jul; 163(1):93-7. PubMed ID: 8010256
    [TBL] [Abstract][Full Text] [Related]  

  • 100. [The role of liver-specific contrast-enhanced MRI before resection of colorectal liver metastases].
    Dede K; Kátai T; Demjén B; Nagy Z; Egyed T; Varga M; Egyed Z; Bursics A
    Orv Hetil; 2021 Dec; 162(50):2010-2016. PubMed ID: 34896985
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.